[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fhdZTJXMu2BtHAHKdfX2CZcw5wvzJfIMuDYKIoL5Toyw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":7,"truncated":8,"activeTrials":9,"phase3Count":10,"totalEnrollment":11,"activePrograms":12,"nonDrugCount":13,"topConditions":14,"upcomingReadouts":37,"phaseBuckets":73,"rows":80},"Aalborg University",[4,6],"Aalborg University Hospital",372,false,72,4,720961,13,305,[15,18,21,24,27,30,32,35],{"name":16,"count":17},"Itch",21,{"name":19,"count":20},"Healthy",18,{"name":22,"count":23},"Pain",14,{"name":25,"count":26},"Low Back Pain",11,{"name":28,"count":29},"Histamine",8,{"name":31,"count":29},"Cowhage",{"name":33,"count":34},"Chronic Pain",7,{"name":36,"count":34},"Heart Failure",[38,43,48,53,58,63,68],{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06456099","Feasibility of a Home Exercise Program With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain","2024-09-30","Ultrasound-guided corticosteroid",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT06686641","Incidence of Macular Edema in a Uveitis Population","2024-10-31","Local and systemical treatment",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT05436054","A Trial to Compare Efficacy and Tolerability of Plenvu® and Picoprep® as Cleansing Agents Before Colonoscopy","2025-12-01","Picoprep",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT07203274","The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch","2026-12-31","Delgocitinib cream",{"nctId":59,"briefTitle":60,"date":61,"intervention":62},"NCT06790082","The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma","2027-04-30","[68Ga]Ga-FAPI-46 PET\u002FCT",{"nctId":64,"briefTitle":65,"date":66,"intervention":67},"NCT07185958","Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy","2028-03-21","Iodine-based contrast agent",{"nctId":69,"briefTitle":70,"date":71,"intervention":72},"NCT05913947","Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)","2028-09-01","Lithium",[74,75,76,77,78,79],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[81,106,124,147,165,191,224,263,288,306,330,348,366,384,426,452,470,495,520,549,567,593,611,636,662,680,705,740,767,785,811,836,862,891,909,927,972,990,1014,1087,1130,1169,1191,1223,1257,1282,1304,1327,1353,1371,1400,1418,1436,1454,1472,1490,1508,1532,1558,1576,1600,1627,1645,1663,1681,1699,1717,1744,1762,1789,1807,1825,1849,1867,1892,1910,1928,1946,1972,2000,2018,2036,2054,2072,2090,2116,2134,2160,2183,2201,2225,2243,2261,2279,2297,2318,2341,2366,2384,2407,2431,2449,2467,2485,2503,2528,2554,2578,2596,2614,2632,2650],{"intervention":52,"totalTrials":82,"cells":83},1,{"EARLY_PHASE1":84,"PHASE1":87,"PHASE2":89,"PHASE3":91,"PHASE4":93,"NA":104},{"trials":85,"activeCount":86},[],0,{"trials":88,"activeCount":86},[],{"trials":90,"activeCount":86},[],{"trials":92,"activeCount":86},[],{"trials":94,"activeCount":82,"soonestReadout":51},[95],{"nctId":49,"briefTitle":50,"status":96,"phases":97,"primaryCompletion":51,"completion":51,"start":98,"enrollment":99,"conditions":100,"interventions":102},"RECRUITING",[78],"2022-10-01",400,[101],"Colon Disease",[52,103],"Plenvu",{"trials":105,"activeCount":86},[],{"intervention":103,"totalTrials":82,"cells":107},{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":114,"PHASE4":116,"NA":122},{"trials":109,"activeCount":86},[],{"trials":111,"activeCount":86},[],{"trials":113,"activeCount":86},[],{"trials":115,"activeCount":86},[],{"trials":117,"activeCount":82,"soonestReadout":51},[118],{"nctId":49,"briefTitle":50,"status":96,"phases":119,"primaryCompletion":51,"completion":51,"start":98,"enrollment":99,"conditions":120,"interventions":121},[78],[101],[52,103],{"trials":123,"activeCount":86},[],{"intervention":72,"totalTrials":82,"cells":125},{"EARLY_PHASE1":126,"PHASE1":128,"PHASE2":130,"PHASE3":132,"PHASE4":134,"NA":145},{"trials":127,"activeCount":86},[],{"trials":129,"activeCount":86},[],{"trials":131,"activeCount":86},[],{"trials":133,"activeCount":86},[],{"trials":135,"activeCount":82,"soonestReadout":71},[136],{"nctId":69,"briefTitle":70,"status":96,"phases":137,"primaryCompletion":71,"completion":138,"start":139,"enrollment":140,"conditions":141,"interventions":143},[78],"2028-09-02","2022-12-13",122,[142],"Depression, Bipolar",[72,144],"Cariprazine",{"trials":146,"activeCount":86},[],{"intervention":144,"totalTrials":82,"cells":148},{"EARLY_PHASE1":149,"PHASE1":151,"PHASE2":153,"PHASE3":155,"PHASE4":157,"NA":163},{"trials":150,"activeCount":86},[],{"trials":152,"activeCount":86},[],{"trials":154,"activeCount":86},[],{"trials":156,"activeCount":86},[],{"trials":158,"activeCount":82,"soonestReadout":71},[159],{"nctId":69,"briefTitle":70,"status":96,"phases":160,"primaryCompletion":71,"completion":138,"start":139,"enrollment":140,"conditions":161,"interventions":162},[78],[142],[72,144],{"trials":164,"activeCount":86},[],{"intervention":62,"totalTrials":82,"cells":166},{"EARLY_PHASE1":167,"PHASE1":169,"PHASE2":171,"PHASE3":185,"PHASE4":187,"NA":189},{"trials":168,"activeCount":86},[],{"trials":170,"activeCount":86},[],{"trials":172,"activeCount":82,"soonestReadout":61},[173],{"nctId":59,"briefTitle":60,"status":96,"phases":174,"primaryCompletion":61,"completion":175,"start":176,"enrollment":177,"conditions":178,"interventions":184},[76],"2037-04-30","2025-01-29",70,[179,180,181,182,183],"Pleural Mesothelioma","Pleural Diseases","Cancer","FAPI","Fibroblast Activation Protein Inhibitor",[62],{"trials":186,"activeCount":86},[],{"trials":188,"activeCount":86},[],{"trials":190,"activeCount":86},[],{"intervention":42,"totalTrials":192,"cells":193},2,{"EARLY_PHASE1":194,"PHASE1":196,"PHASE2":198,"PHASE3":200,"PHASE4":202,"NA":204},{"trials":195,"activeCount":86},[],{"trials":197,"activeCount":86},[],{"trials":199,"activeCount":86},[],{"trials":201,"activeCount":86},[],{"trials":203,"activeCount":86},[],{"trials":205,"activeCount":82,"soonestReadout":41},[206,213],{"nctId":39,"briefTitle":40,"status":96,"phases":207,"primaryCompletion":41,"completion":41,"start":208,"enrollment":209,"conditions":210,"interventions":212},[79],"2024-06-07",20,[211],"Greater Trochanteric Pain Syndrome",[42],{"nctId":214,"briefTitle":215,"status":216,"phases":217,"primaryCompletion":218,"completion":218,"start":219,"enrollment":220,"conditions":221,"interventions":223},"NCT03804008","Advice vs Advice + Exercise vs Advice + Exercise + Injection for Individuals With Plantar Fasciopathy","COMPLETED",[79],"2021-09-23","2019-02-07",180,[222],"Plantar Fasciopathy",[42],{"intervention":225,"totalTrials":192,"cells":226},"Vehicle",{"EARLY_PHASE1":227,"PHASE1":229,"PHASE2":231,"PHASE3":233,"PHASE4":235,"NA":237},{"trials":228,"activeCount":86},[],{"trials":230,"activeCount":86},[],{"trials":232,"activeCount":86},[],{"trials":234,"activeCount":86},[],{"trials":236,"activeCount":86},[],{"trials":238,"activeCount":82,"soonestReadout":56},[239,249],{"nctId":54,"briefTitle":55,"status":240,"phases":241,"primaryCompletion":56,"completion":56,"start":242,"enrollment":243,"conditions":244,"interventions":246},"NOT_YET_RECRUITING",[79],"2026-05-01",30,[245],"Itchiness",[57,247,248,225],"lidocaine cream","Lidocaine+Delgocitinib",{"nctId":250,"briefTitle":251,"status":216,"phases":252,"primaryCompletion":253,"completion":254,"start":255,"enrollment":256,"conditions":257,"interventions":258},"NCT06036589","Characterization of Bovine Adrenal Medulla as a Model of Non-histaminergic Itch",[79],"2022-05-30","2022-10-30","2022-03-10",25,[16],[259,260,261,262],"CA and BAM8-22","Vehicle and BAM8-22 application","CA","vehicle",{"intervention":67,"totalTrials":82,"cells":264},{"EARLY_PHASE1":265,"PHASE1":267,"PHASE2":269,"PHASE3":271,"PHASE4":273,"NA":275},{"trials":266,"activeCount":86},[],{"trials":268,"activeCount":86},[],{"trials":270,"activeCount":86},[],{"trials":272,"activeCount":86},[],{"trials":274,"activeCount":86},[],{"trials":276,"activeCount":82,"soonestReadout":66},[277],{"nctId":64,"briefTitle":65,"status":240,"phases":278,"primaryCompletion":66,"completion":66,"start":279,"enrollment":280,"conditions":281,"interventions":286},[],"2025-09-22",80,[282,283,284,285],"Brain Metastases","Bone Metastases","Head and Neck Cancer","Lung Cancer",[67,287],"Gadolinium-based contrast agent",{"intervention":287,"totalTrials":82,"cells":289},{"EARLY_PHASE1":290,"PHASE1":292,"PHASE2":294,"PHASE3":296,"PHASE4":298,"NA":300},{"trials":291,"activeCount":86},[],{"trials":293,"activeCount":86},[],{"trials":295,"activeCount":86},[],{"trials":297,"activeCount":86},[],{"trials":299,"activeCount":86},[],{"trials":301,"activeCount":82,"soonestReadout":66},[302],{"nctId":64,"briefTitle":65,"status":240,"phases":303,"primaryCompletion":66,"completion":66,"start":279,"enrollment":280,"conditions":304,"interventions":305},[],[282,283,284,285],[67,287],{"intervention":47,"totalTrials":82,"cells":307},{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":316,"NA":318},{"trials":309,"activeCount":86},[],{"trials":311,"activeCount":86},[],{"trials":313,"activeCount":86},[],{"trials":315,"activeCount":86},[],{"trials":317,"activeCount":86},[],{"trials":319,"activeCount":82,"soonestReadout":46},[320],{"nctId":44,"briefTitle":45,"status":321,"phases":322,"primaryCompletion":46,"completion":323,"start":324,"enrollment":325,"conditions":326,"interventions":329},"ACTIVE_NOT_RECRUITING",[],"2025-02-01","2024-05-01",1550,[327,328],"Macular Edema","Non-infectious Uveitis",[47],{"intervention":57,"totalTrials":82,"cells":331},{"EARLY_PHASE1":332,"PHASE1":334,"PHASE2":336,"PHASE3":338,"PHASE4":340,"NA":342},{"trials":333,"activeCount":86},[],{"trials":335,"activeCount":86},[],{"trials":337,"activeCount":86},[],{"trials":339,"activeCount":86},[],{"trials":341,"activeCount":86},[],{"trials":343,"activeCount":82,"soonestReadout":56},[344],{"nctId":54,"briefTitle":55,"status":240,"phases":345,"primaryCompletion":56,"completion":56,"start":242,"enrollment":243,"conditions":346,"interventions":347},[79],[245],[57,247,248,225],{"intervention":247,"totalTrials":82,"cells":349},{"EARLY_PHASE1":350,"PHASE1":352,"PHASE2":354,"PHASE3":356,"PHASE4":358,"NA":360},{"trials":351,"activeCount":86},[],{"trials":353,"activeCount":86},[],{"trials":355,"activeCount":86},[],{"trials":357,"activeCount":86},[],{"trials":359,"activeCount":86},[],{"trials":361,"activeCount":82,"soonestReadout":56},[362],{"nctId":54,"briefTitle":55,"status":240,"phases":363,"primaryCompletion":56,"completion":56,"start":242,"enrollment":243,"conditions":364,"interventions":365},[79],[245],[57,247,248,225],{"intervention":248,"totalTrials":82,"cells":367},{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":378},{"trials":369,"activeCount":86},[],{"trials":371,"activeCount":86},[],{"trials":373,"activeCount":86},[],{"trials":375,"activeCount":86},[],{"trials":377,"activeCount":86},[],{"trials":379,"activeCount":82,"soonestReadout":56},[380],{"nctId":54,"briefTitle":55,"status":240,"phases":381,"primaryCompletion":56,"completion":56,"start":242,"enrollment":243,"conditions":382,"interventions":383},[79],[245],[57,247,248,225],{"intervention":385,"totalTrials":192,"cells":386},"Oxygen",{"EARLY_PHASE1":387,"PHASE1":389,"PHASE2":391,"PHASE3":393,"PHASE4":395,"NA":424},{"trials":388,"activeCount":86},[],{"trials":390,"activeCount":86},[],{"trials":392,"activeCount":86},[],{"trials":394,"activeCount":86},[],{"trials":396,"activeCount":86},[397,409],{"nctId":398,"briefTitle":399,"status":216,"phases":400,"primaryCompletion":401,"completion":402,"start":403,"enrollment":404,"conditions":405,"interventions":408},"NCT03174002","Handling Oxygenation Targets in the Intensive Care Unit",[78],"2020-11-03","2021-08-03","2017-06-19",2928,[406,407],"Hypoxemic Respiratory Failure","Oxygen Toxicity",[385,385],{"nctId":410,"briefTitle":411,"status":412,"phases":413,"primaryCompletion":414,"completion":415,"start":416,"enrollment":417,"conditions":418,"interventions":423},"NCT04133740","Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study","UNKNOWN",[78],"2019-07-15","2020-07-31","2018-10-01",50,[419,420,421,422,407],"Hyperoxia","Cardiac Surgery","Cardiopulmonary Bypass","Acute Lung Injury",[385],{"trials":425,"activeCount":86},[],{"intervention":427,"totalTrials":82,"cells":428},"Low oxygenation target",{"EARLY_PHASE1":429,"PHASE1":431,"PHASE2":433,"PHASE3":435,"PHASE4":437,"NA":450},{"trials":430,"activeCount":86},[],{"trials":432,"activeCount":86},[],{"trials":434,"activeCount":86},[],{"trials":436,"activeCount":86},[],{"trials":438,"activeCount":86},[439],{"nctId":440,"briefTitle":441,"status":216,"phases":442,"primaryCompletion":443,"completion":444,"start":445,"enrollment":446,"conditions":447,"interventions":448},"NCT04425031","Handling Oxygenation Targets in COVID-19",[78],"2023-03-08","2024-03-08","2020-08-25",726,[406,407],[427,449],"High oxygenation target",{"trials":451,"activeCount":86},[],{"intervention":449,"totalTrials":82,"cells":453},{"EARLY_PHASE1":454,"PHASE1":456,"PHASE2":458,"PHASE3":460,"PHASE4":462,"NA":468},{"trials":455,"activeCount":86},[],{"trials":457,"activeCount":86},[],{"trials":459,"activeCount":86},[],{"trials":461,"activeCount":86},[],{"trials":463,"activeCount":86},[464],{"nctId":440,"briefTitle":441,"status":216,"phases":465,"primaryCompletion":443,"completion":444,"start":445,"enrollment":446,"conditions":466,"interventions":467},[78],[406,407],[427,449],{"trials":469,"activeCount":86},[],{"intervention":471,"totalTrials":82,"cells":472},"Aspirin",{"EARLY_PHASE1":473,"PHASE1":475,"PHASE2":477,"PHASE3":479,"PHASE4":481,"NA":493},{"trials":474,"activeCount":86},[],{"trials":476,"activeCount":86},[],{"trials":478,"activeCount":86},[],{"trials":480,"activeCount":86},[],{"trials":482,"activeCount":86},[483],{"nctId":484,"briefTitle":485,"status":216,"phases":486,"primaryCompletion":487,"completion":487,"start":488,"enrollment":489,"conditions":490,"interventions":492},"NCT00262561","Resistance to Aspirin and\u002For Clopidogrel Among Patients With PAD.",[78],"2008-01","2006-01",263,[491],"Intermittent Claudication",[471],{"trials":494,"activeCount":86},[],{"intervention":496,"totalTrials":82,"cells":497},"Psyllium husks",{"EARLY_PHASE1":498,"PHASE1":500,"PHASE2":502,"PHASE3":504,"PHASE4":506,"NA":518},{"trials":499,"activeCount":86},[],{"trials":501,"activeCount":86},[],{"trials":503,"activeCount":86},[],{"trials":505,"activeCount":86},[],{"trials":507,"activeCount":86},[508],{"nctId":509,"briefTitle":510,"status":216,"phases":511,"primaryCompletion":512,"completion":512,"start":513,"enrollment":514,"conditions":515,"interventions":517},"NCT01251991","Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia",[78],"2012-01","2011-01",41,[516],"Hypercholesterolemia",[496],{"trials":519,"activeCount":86},[],{"intervention":521,"totalTrials":82,"cells":522},"Ibuprofene",{"EARLY_PHASE1":523,"PHASE1":525,"PHASE2":527,"PHASE3":529,"PHASE4":531,"NA":547},{"trials":524,"activeCount":86},[],{"trials":526,"activeCount":86},[],{"trials":528,"activeCount":86},[],{"trials":530,"activeCount":86},[],{"trials":532,"activeCount":86},[533],{"nctId":534,"briefTitle":535,"status":216,"phases":536,"primaryCompletion":537,"completion":538,"start":539,"enrollment":540,"conditions":541,"interventions":545},"NCT02479165","Pain Management After Cardiac Surgery - Opioids or NSAID",[78],"2010-09","2013-09","2009-05",182,[542,543,544],"Postoperative Pain","Renal Insufficiency","Myocardial Infarction",[521,546],"Oxycodone",{"trials":548,"activeCount":86},[],{"intervention":546,"totalTrials":82,"cells":550},{"EARLY_PHASE1":551,"PHASE1":553,"PHASE2":555,"PHASE3":557,"PHASE4":559,"NA":565},{"trials":552,"activeCount":86},[],{"trials":554,"activeCount":86},[],{"trials":556,"activeCount":86},[],{"trials":558,"activeCount":86},[],{"trials":560,"activeCount":86},[561],{"nctId":534,"briefTitle":535,"status":216,"phases":562,"primaryCompletion":537,"completion":538,"start":539,"enrollment":540,"conditions":563,"interventions":564},[78],[542,543,544],[521,546],{"trials":566,"activeCount":86},[],{"intervention":568,"totalTrials":82,"cells":569},"unfractionated heparin",{"EARLY_PHASE1":570,"PHASE1":572,"PHASE2":574,"PHASE3":576,"PHASE4":589,"NA":591},{"trials":571,"activeCount":86},[],{"trials":573,"activeCount":86},[],{"trials":575,"activeCount":86},[],{"trials":577,"activeCount":86},[578],{"nctId":579,"briefTitle":580,"status":216,"phases":581,"primaryCompletion":582,"completion":582,"start":583,"enrollment":584,"conditions":585,"interventions":587},"NCT00628576","Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities",[77],"2004-06","1993-10",99,[586],"Deep Venous Thrombosis",[568,588],"Tinzaparin",{"trials":590,"activeCount":86},[],{"trials":592,"activeCount":86},[],{"intervention":588,"totalTrials":82,"cells":594},{"EARLY_PHASE1":595,"PHASE1":597,"PHASE2":599,"PHASE3":601,"PHASE4":607,"NA":609},{"trials":596,"activeCount":86},[],{"trials":598,"activeCount":86},[],{"trials":600,"activeCount":86},[],{"trials":602,"activeCount":86},[603],{"nctId":579,"briefTitle":580,"status":216,"phases":604,"primaryCompletion":582,"completion":582,"start":583,"enrollment":584,"conditions":605,"interventions":606},[77],[586],[568,588],{"trials":608,"activeCount":86},[],{"trials":610,"activeCount":86},[],{"intervention":612,"totalTrials":82,"cells":613},"Pregabalin",{"EARLY_PHASE1":614,"PHASE1":616,"PHASE2":618,"PHASE3":620,"PHASE4":632,"NA":634},{"trials":615,"activeCount":86},[],{"trials":617,"activeCount":86},[],{"trials":619,"activeCount":86},[],{"trials":621,"activeCount":86},[622],{"nctId":623,"briefTitle":624,"status":216,"phases":625,"primaryCompletion":626,"completion":626,"start":627,"enrollment":628,"conditions":629,"interventions":631},"NCT00755573","Pain and Chronic Pancreatitis - Clinical End Experimental Studies",[76,77],"2010-05","2008-10",64,[630],"Chronic Pancreatitis",[612],{"trials":633,"activeCount":86},[],{"trials":635,"activeCount":86},[],{"intervention":637,"totalTrials":82,"cells":638},"Twinrix",{"EARLY_PHASE1":639,"PHASE1":641,"PHASE2":643,"PHASE3":645,"PHASE4":658,"NA":660},{"trials":640,"activeCount":86},[],{"trials":642,"activeCount":86},[],{"trials":644,"activeCount":86},[],{"trials":646,"activeCount":86},[647],{"nctId":648,"briefTitle":649,"status":412,"phases":650,"start":651,"enrollment":280,"conditions":652,"interventions":656},"NCT00451984","Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2",[77],"2007-03",[653,654,655],"HIV Infections","Hepatitis A","Hepatitis B",[637,657],"interleukin-2",{"trials":659,"activeCount":86},[],{"trials":661,"activeCount":86},[],{"intervention":657,"totalTrials":82,"cells":663},{"EARLY_PHASE1":664,"PHASE1":666,"PHASE2":668,"PHASE3":670,"PHASE4":676,"NA":678},{"trials":665,"activeCount":86},[],{"trials":667,"activeCount":86},[],{"trials":669,"activeCount":86},[],{"trials":671,"activeCount":86},[672],{"nctId":648,"briefTitle":649,"status":412,"phases":673,"start":651,"enrollment":280,"conditions":674,"interventions":675},[77],[653,654,655],[637,657],{"trials":677,"activeCount":86},[],{"trials":679,"activeCount":86},[],{"intervention":681,"totalTrials":82,"cells":682},"D3 Vitamin ®",{"EARLY_PHASE1":683,"PHASE1":685,"PHASE2":687,"PHASE3":689,"PHASE4":701,"NA":703},{"trials":684,"activeCount":86},[],{"trials":686,"activeCount":86},[],{"trials":688,"activeCount":86},[],{"trials":690,"activeCount":86},[691],{"nctId":692,"briefTitle":693,"status":216,"phases":694,"primaryCompletion":695,"completion":695,"start":696,"enrollment":697,"conditions":698,"interventions":700},"NCT01695460","A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine",[77],"2015-12","2012-09",48,[699],"Migraine According to International Headache Society (IHS) Criteria (ICHD-II)",[681],{"trials":702,"activeCount":86},[],{"trials":704,"activeCount":86},[],{"intervention":706,"totalTrials":192,"cells":707},"68Ga-FAPi-46",{"EARLY_PHASE1":708,"PHASE1":710,"PHASE2":712,"PHASE3":734,"PHASE4":736,"NA":738},{"trials":709,"activeCount":86},[],{"trials":711,"activeCount":86},[],{"trials":713,"activeCount":86},[714,724],{"nctId":715,"briefTitle":716,"status":216,"phases":717,"primaryCompletion":718,"completion":718,"start":719,"enrollment":209,"conditions":720,"interventions":723},"NCT05898854","[68Ga]Ga-FAPI PET\u002FCT in Gastric and Gastroesophageal Junctional Cancer",[76],"2025-12-18","2024-02-15",[721,722,181],"Gastric Cancer","Gastro Esophageal Junctional Cancer",[706],{"nctId":725,"briefTitle":726,"status":727,"phases":728,"primaryCompletion":729,"completion":729,"start":730,"enrollment":209,"conditions":731,"interventions":733},"NCT05903807","[68Ga]Ga-FAPI-46 PET\u002FCT in Ovarian Cancer","TERMINATED",[76],"2026-05-08","2023-11-17",[732],"Ovarian Cancer",[706],{"trials":735,"activeCount":86},[],{"trials":737,"activeCount":86},[],{"trials":739,"activeCount":86},[],{"intervention":741,"totalTrials":82,"cells":742},"r-metHuSCF and Filgrastim",{"EARLY_PHASE1":743,"PHASE1":745,"PHASE2":747,"PHASE3":761,"PHASE4":763,"NA":765},{"trials":744,"activeCount":86},[],{"trials":746,"activeCount":86},[],{"trials":748,"activeCount":86},[749],{"nctId":750,"briefTitle":751,"status":727,"phases":752,"primaryCompletion":753,"completion":754,"start":755,"enrollment":756,"conditions":757,"interventions":759},"NCT01016795","Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma",[76],"2000-11","2009-11","1999-01",32,[758],"Malignant Lymphoma",[741,741,760],"Chemotherapy plus Filgrastim",{"trials":762,"activeCount":86},[],{"trials":764,"activeCount":86},[],{"trials":766,"activeCount":86},[],{"intervention":760,"totalTrials":82,"cells":768},{"EARLY_PHASE1":769,"PHASE1":771,"PHASE2":773,"PHASE3":779,"PHASE4":781,"NA":783},{"trials":770,"activeCount":86},[],{"trials":772,"activeCount":86},[],{"trials":774,"activeCount":86},[775],{"nctId":750,"briefTitle":751,"status":727,"phases":776,"primaryCompletion":753,"completion":754,"start":755,"enrollment":756,"conditions":777,"interventions":778},[76],[758],[741,741,760],{"trials":780,"activeCount":86},[],{"trials":782,"activeCount":86},[],{"trials":784,"activeCount":86},[],{"intervention":786,"totalTrials":82,"cells":787},"Cannabidiol",{"EARLY_PHASE1":788,"PHASE1":790,"PHASE2":792,"PHASE3":805,"PHASE4":807,"NA":809},{"trials":789,"activeCount":86},[],{"trials":791,"activeCount":86},[],{"trials":793,"activeCount":86},[794],{"nctId":795,"briefTitle":796,"status":216,"phases":797,"primaryCompletion":798,"completion":798,"start":799,"enrollment":800,"conditions":801,"interventions":804},"NCT03693833","CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.",[76],"2021-06-01","2018-11-28",136,[802,803],"Psoriatic Arthritis","Hand Osteoarthritis",[786],{"trials":806,"activeCount":86},[],{"trials":808,"activeCount":86},[],{"trials":810,"activeCount":86},[],{"intervention":812,"totalTrials":82,"cells":813},"lipid emulsion with a high content of n-3 fatty acids",{"EARLY_PHASE1":814,"PHASE1":816,"PHASE2":818,"PHASE3":830,"PHASE4":832,"NA":834},{"trials":815,"activeCount":86},[],{"trials":817,"activeCount":86},[],{"trials":819,"activeCount":86},[820],{"nctId":821,"briefTitle":822,"status":216,"phases":823,"primaryCompletion":824,"completion":824,"start":825,"enrollment":826,"conditions":827,"interventions":829},"NCT00259025","Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients",[76],"2007-07","2006-09",60,[828],"Renal Failure, Chronic",[812],{"trials":831,"activeCount":86},[],{"trials":833,"activeCount":86},[],{"trials":835,"activeCount":86},[],{"intervention":837,"totalTrials":82,"cells":838},"Omegaven",{"EARLY_PHASE1":839,"PHASE1":841,"PHASE2":843,"PHASE3":856,"PHASE4":858,"NA":860},{"trials":840,"activeCount":86},[],{"trials":842,"activeCount":86},[],{"trials":844,"activeCount":86},[845],{"nctId":846,"briefTitle":847,"status":216,"phases":848,"primaryCompletion":849,"completion":849,"start":850,"enrollment":29,"conditions":851,"interventions":854},"NCT00534300","Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker",[75,76],"2008-06","2007-10",[852,853],"Ventricular Tachycardia","Sudden Cardiac Death",[837,855],"Isotonic saline",{"trials":857,"activeCount":86},[],{"trials":859,"activeCount":86},[],{"trials":861,"activeCount":86},[],{"intervention":863,"totalTrials":82,"cells":864},"Human Intravenous Immunoglobulins,",{"EARLY_PHASE1":865,"PHASE1":867,"PHASE2":869,"PHASE3":885,"PHASE4":887,"NA":889},{"trials":866,"activeCount":86},[],{"trials":868,"activeCount":86},[],{"trials":870,"activeCount":86},[871],{"nctId":872,"briefTitle":873,"status":216,"phases":874,"primaryCompletion":875,"completion":875,"start":876,"enrollment":280,"conditions":877,"interventions":882},"NCT04701034","Intravenous Immunoglobulin and Prednisolone for RPL After ART.",[76],"2024-04-18","2021-01-28",[878,879,880,881],"Habitual Abortion","Recurrent Pregnancy Loss","Fertility Disorders","Miscarriage",[863,883,884],"Prednisolone","Human Albumin Solution",{"trials":886,"activeCount":86},[],{"trials":888,"activeCount":86},[],{"trials":890,"activeCount":86},[],{"intervention":883,"totalTrials":82,"cells":892},{"EARLY_PHASE1":893,"PHASE1":895,"PHASE2":897,"PHASE3":903,"PHASE4":905,"NA":907},{"trials":894,"activeCount":86},[],{"trials":896,"activeCount":86},[],{"trials":898,"activeCount":86},[899],{"nctId":872,"briefTitle":873,"status":216,"phases":900,"primaryCompletion":875,"completion":875,"start":876,"enrollment":280,"conditions":901,"interventions":902},[76],[878,879,880,881],[863,883,884],{"trials":904,"activeCount":86},[],{"trials":906,"activeCount":86},[],{"trials":908,"activeCount":86},[],{"intervention":884,"totalTrials":82,"cells":910},{"EARLY_PHASE1":911,"PHASE1":913,"PHASE2":915,"PHASE3":921,"PHASE4":923,"NA":925},{"trials":912,"activeCount":86},[],{"trials":914,"activeCount":86},[],{"trials":916,"activeCount":86},[917],{"nctId":872,"briefTitle":873,"status":216,"phases":918,"primaryCompletion":875,"completion":875,"start":876,"enrollment":280,"conditions":919,"interventions":920},[76],[878,879,880,881],[863,883,884],{"trials":922,"activeCount":86},[],{"trials":924,"activeCount":86},[],{"trials":926,"activeCount":86},[],{"intervention":928,"totalTrials":929,"cells":930},"NGF",3,{"EARLY_PHASE1":931,"PHASE1":962,"PHASE2":964,"PHASE3":966,"PHASE4":968,"NA":970},{"trials":932,"activeCount":86},[933,945,953],{"nctId":934,"briefTitle":935,"status":216,"phases":936,"primaryCompletion":937,"completion":938,"start":939,"enrollment":17,"conditions":940,"interventions":944},"NCT03470038","Interaction Between NGF and Acute Exercise-induced Ischemia",[74],"2018-05-15","2018-06-15","2018-03-15",[941,942,943],"Hyperalgesia","Pain Response","Healthy Subjects",[928,855],{"nctId":946,"briefTitle":947,"status":216,"phases":948,"primaryCompletion":949,"completion":949,"start":950,"enrollment":209,"conditions":951,"interventions":952},"NCT03217942","Spread of Muscle Hyperalgesia and Pain in a Low Dose NGF-induced Pain Model",[74],"2017-10-01","2017-07-01",[941,943],[928],{"nctId":954,"briefTitle":955,"status":412,"phases":956,"primaryCompletion":957,"completion":957,"start":958,"enrollment":209,"conditions":959,"interventions":960},"NCT03844243","Exercise-induced Ischemia and the Influence of Pain Modulation in a Nerve Growth Factor (NGF) Model",[74],"2019-06-30","2019-02-18",[942,941,943],[928,961],"Isotonic-saline",{"trials":963,"activeCount":86},[],{"trials":965,"activeCount":86},[],{"trials":967,"activeCount":86},[],{"trials":969,"activeCount":86},[],{"trials":971,"activeCount":86},[],{"intervention":961,"totalTrials":82,"cells":973},{"EARLY_PHASE1":974,"PHASE1":980,"PHASE2":982,"PHASE3":984,"PHASE4":986,"NA":988},{"trials":975,"activeCount":86},[976],{"nctId":954,"briefTitle":955,"status":412,"phases":977,"primaryCompletion":957,"completion":957,"start":958,"enrollment":209,"conditions":978,"interventions":979},[74],[942,941,943],[928,961],{"trials":981,"activeCount":86},[],{"trials":983,"activeCount":86},[],{"trials":985,"activeCount":86},[],{"trials":987,"activeCount":86},[],{"trials":989,"activeCount":86},[],{"intervention":991,"totalTrials":82,"cells":992},"Advanced platelet-rich fibrin in the ekstraction socket",{"EARLY_PHASE1":993,"PHASE1":1004,"PHASE2":1006,"PHASE3":1008,"PHASE4":1010,"NA":1012},{"trials":994,"activeCount":86},[995],{"nctId":996,"briefTitle":997,"status":412,"phases":998,"primaryCompletion":999,"completion":51,"start":1000,"enrollment":280,"conditions":1001,"interventions":1003},"NCT06377839","Pain After Removal of Mandibular Third Molars With or Without Advanced Platelet-rich Fibrin",[74],"2024-04-17","2024-01-10",[1002],"Pain Syndrome",[991],{"trials":1005,"activeCount":86},[],{"trials":1007,"activeCount":86},[],{"trials":1009,"activeCount":86},[],{"trials":1011,"activeCount":86},[],{"trials":1013,"activeCount":86},[],{"intervention":855,"totalTrials":1015,"cells":1016},6,{"EARLY_PHASE1":1017,"PHASE1":1023,"PHASE2":1025,"PHASE3":1031,"PHASE4":1033,"NA":1035},{"trials":1018,"activeCount":86},[1019],{"nctId":934,"briefTitle":935,"status":216,"phases":1020,"primaryCompletion":937,"completion":938,"start":939,"enrollment":17,"conditions":1021,"interventions":1022},[74],[941,942,943],[928,855],{"trials":1024,"activeCount":86},[],{"trials":1026,"activeCount":86},[1027],{"nctId":846,"briefTitle":847,"status":216,"phases":1028,"primaryCompletion":849,"completion":849,"start":850,"enrollment":29,"conditions":1029,"interventions":1030},[75,76],[852,853],[837,855],{"trials":1032,"activeCount":86},[],{"trials":1034,"activeCount":86},[],{"trials":1036,"activeCount":86},[1037,1052,1064,1076],{"nctId":1038,"briefTitle":1039,"status":216,"phases":1040,"primaryCompletion":1041,"completion":1042,"start":1043,"enrollment":826,"conditions":1044,"interventions":1049},"NCT04146311","Effect of Short-term Motor Training on Accuracy and Precision of Knee Movement in Human With and Without Knee Pain",[79],"2020-11-28","2020-12-20","2019-10-30",[1045,1046,1047,1048],"Isotonic Saline","Hypertonic Saline","Healthy Eld Human","Knee Pain Chronic",[1050,1051],"Hypertonic saline","isotonic saline",{"nctId":1053,"briefTitle":1054,"status":412,"phases":1055,"primaryCompletion":1056,"completion":1057,"start":1058,"enrollment":1059,"conditions":1060,"interventions":1062},"NCT04787198","Investigating Composite Biomarkers for Pain Catastrophizing",[79],"2024-12-31","2025-12-31","2022-10-15",44,[1061],"Pain, Acute",[1063,1051],"hypertonic saline",{"nctId":1065,"briefTitle":1066,"status":216,"phases":1067,"primaryCompletion":1068,"completion":1068,"start":1069,"enrollment":1070,"conditions":1071,"interventions":1072},"NCT04700007","Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine (Second Sub-Project)",[79],"2021-12-31","2021-01-18",26,[16],[1073,1074,1075,855,28],"Capsaicin","Diphenhydramine","Morphine Chloride",{"nctId":1077,"briefTitle":1078,"status":216,"phases":1079,"primaryCompletion":1080,"completion":1081,"start":1082,"enrollment":1083,"conditions":1084,"interventions":1086},"NCT04115462","A Relation of Morphine-induced Itch and Pain Processing",[79],"2020-05-01","2020-07-07","2020-01-15",24,[1085,16],"Morphine",[1085,28,31,1051,28,31],{"intervention":28,"totalTrials":10,"cells":1088},{"EARLY_PHASE1":1089,"PHASE1":1091,"PHASE2":1093,"PHASE3":1095,"PHASE4":1097,"NA":1099},{"trials":1090,"activeCount":86},[],{"trials":1092,"activeCount":86},[],{"trials":1094,"activeCount":86},[],{"trials":1096,"activeCount":86},[],{"trials":1098,"activeCount":86},[],{"trials":1100,"activeCount":86},[1101,1111,1115,1119],{"nctId":1102,"briefTitle":1103,"status":216,"phases":1104,"primaryCompletion":1105,"completion":798,"start":1106,"enrollment":1083,"conditions":1107,"interventions":1108},"NCT04588532","Characterization of BAM8-22 as a New Surrogate Model of Non-histaminergic Itch",[79],"2021-05-01","2020-10-01",[16],[1109,28,31,1110],"BAM8-22","Doxepin",{"nctId":1065,"briefTitle":1066,"status":216,"phases":1112,"primaryCompletion":1068,"completion":1068,"start":1069,"enrollment":1070,"conditions":1113,"interventions":1114},[79],[16],[1073,1074,1075,855,28],{"nctId":1077,"briefTitle":1078,"status":216,"phases":1116,"primaryCompletion":1080,"completion":1081,"start":1082,"enrollment":1083,"conditions":1117,"interventions":1118},[79],[1085,16],[1085,28,31,1051,28,31],{"nctId":1120,"briefTitle":1121,"status":216,"phases":1122,"primaryCompletion":1123,"completion":1124,"start":1125,"enrollment":209,"conditions":1126,"interventions":1127},"NCT04554888","Characterization of New Human Models of Non-histaminergic Itch and Their Interaction With the TRPM8 Receptor",[79],"2022-05-31","2022-06-30","2022-03-01",[16],[1128,1129,28],"Doxepin Topical","Papain",{"intervention":1131,"totalTrials":192,"cells":1132},"Lidocaine",{"EARLY_PHASE1":1133,"PHASE1":1135,"PHASE2":1137,"PHASE3":1139,"PHASE4":1141,"NA":1143},{"trials":1134,"activeCount":86},[],{"trials":1136,"activeCount":86},[],{"trials":1138,"activeCount":86},[],{"trials":1140,"activeCount":86},[],{"trials":1142,"activeCount":86},[],{"trials":1144,"activeCount":86},[1145,1157],{"nctId":1146,"briefTitle":1147,"status":216,"phases":1148,"primaryCompletion":1149,"completion":1150,"start":1151,"enrollment":1152,"conditions":1153,"interventions":1156},"NCT03576053","A Mechanistic Evaluation of the Interactions Between Thermoceptive and Pruriceptive Sensory Processing",[79],"2019-07-31","2019-08-28","2018-07-01",59,[16,1154,28,31,1155],"Thermal Stimulation","Serotonine",[1131],{"nctId":1158,"briefTitle":1159,"status":216,"phases":1160,"primaryCompletion":1161,"completion":1162,"start":1163,"enrollment":1059,"conditions":1164,"interventions":1167},"NCT03587220","A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin",[79],"2019-08-31","2019-12-31","2018-08-01",[1073,1165,1166,1131],"Ultaviolet B Light Burn","Neuropathic Pain",[1168,1131],"Capsaicin Topical",{"intervention":1050,"totalTrials":192,"cells":1170},{"EARLY_PHASE1":1171,"PHASE1":1173,"PHASE2":1175,"PHASE3":1177,"PHASE4":1179,"NA":1181},{"trials":1172,"activeCount":86},[],{"trials":1174,"activeCount":86},[],{"trials":1176,"activeCount":86},[],{"trials":1178,"activeCount":86},[],{"trials":1180,"activeCount":86},[],{"trials":1182,"activeCount":86},[1183,1187],{"nctId":1038,"briefTitle":1039,"status":216,"phases":1184,"primaryCompletion":1041,"completion":1042,"start":1043,"enrollment":826,"conditions":1185,"interventions":1186},[79],[1045,1046,1047,1048],[1050,1051],{"nctId":1053,"briefTitle":1054,"status":412,"phases":1188,"primaryCompletion":1056,"completion":1057,"start":1058,"enrollment":1059,"conditions":1189,"interventions":1190},[79],[1061],[1063,1051],{"intervention":1073,"totalTrials":192,"cells":1192},{"EARLY_PHASE1":1193,"PHASE1":1195,"PHASE2":1197,"PHASE3":1199,"PHASE4":1201,"NA":1203},{"trials":1194,"activeCount":86},[],{"trials":1196,"activeCount":86},[],{"trials":1198,"activeCount":86},[],{"trials":1200,"activeCount":86},[],{"trials":1202,"activeCount":86},[],{"trials":1204,"activeCount":86},[1205,1219],{"nctId":1206,"briefTitle":1207,"status":412,"phases":1208,"primaryCompletion":1209,"completion":1209,"start":1210,"enrollment":1211,"conditions":1212,"interventions":1215},"NCT03132142","Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol",[79],"2017-08","2017-04",22,[22,1213,1166,1214],"Pruritus","Dermatology\u002FSkin - Other",[1073,1216,1217,1218],"Trans-cinnamaldehyde","L-Menthol","Vehicle patch",{"nctId":1065,"briefTitle":1066,"status":216,"phases":1220,"primaryCompletion":1068,"completion":1068,"start":1069,"enrollment":1070,"conditions":1221,"interventions":1222},[79],[16],[1073,1074,1075,855,28],{"intervention":1224,"totalTrials":192,"cells":1225},"Corticosteroid",{"EARLY_PHASE1":1226,"PHASE1":1228,"PHASE2":1230,"PHASE3":1232,"PHASE4":1234,"NA":1236},{"trials":1227,"activeCount":86},[],{"trials":1229,"activeCount":86},[],{"trials":1231,"activeCount":86},[],{"trials":1233,"activeCount":86},[],{"trials":1235,"activeCount":86},[],{"trials":1237,"activeCount":86},[1238,1247],{"nctId":1239,"briefTitle":1240,"status":216,"phases":1241,"primaryCompletion":1242,"completion":1242,"start":1243,"enrollment":209,"conditions":1244,"interventions":1246},"NCT03535896","Heavy-slow Resistance Training and Ultrasound-guided Corticosteroid Injection in Plantar Fasciopathy",[79],"2018-10-11","2018-06-08",[1245,222],"Plantar Heel Pain",[1224],{"nctId":1248,"briefTitle":1249,"status":216,"phases":1250,"primaryCompletion":1251,"completion":1252,"start":1253,"enrollment":417,"conditions":1254,"interventions":1256},"NCT03821155","Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis?",[79],"2021-07-01","2022-01-01","2019-02-01",[1255],"Vestibular Neuritis",[1224],{"intervention":1085,"totalTrials":192,"cells":1258},{"EARLY_PHASE1":1259,"PHASE1":1261,"PHASE2":1263,"PHASE3":1265,"PHASE4":1267,"NA":1269},{"trials":1260,"activeCount":86},[],{"trials":1262,"activeCount":86},[],{"trials":1264,"activeCount":86},[],{"trials":1266,"activeCount":86},[],{"trials":1268,"activeCount":86},[],{"trials":1270,"activeCount":86},[1271,1278],{"nctId":1272,"briefTitle":1273,"status":216,"phases":1274,"primaryCompletion":1123,"completion":1275,"start":1251,"enrollment":1070,"conditions":1276,"interventions":1277},"NCT04672382","Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine",[79],"2022-12-31",[1085,28,31,1045],[1085],{"nctId":1077,"briefTitle":1078,"status":216,"phases":1279,"primaryCompletion":1080,"completion":1081,"start":1082,"enrollment":1083,"conditions":1280,"interventions":1281},[79],[1085,16],[1085,28,31,1051,28,31],{"intervention":31,"totalTrials":192,"cells":1283},{"EARLY_PHASE1":1284,"PHASE1":1286,"PHASE2":1288,"PHASE3":1290,"PHASE4":1292,"NA":1294},{"trials":1285,"activeCount":86},[],{"trials":1287,"activeCount":86},[],{"trials":1289,"activeCount":86},[],{"trials":1291,"activeCount":86},[],{"trials":1293,"activeCount":86},[],{"trials":1295,"activeCount":86},[1296,1300],{"nctId":1102,"briefTitle":1103,"status":216,"phases":1297,"primaryCompletion":1105,"completion":798,"start":1106,"enrollment":1083,"conditions":1298,"interventions":1299},[79],[16],[1109,28,31,1110],{"nctId":1077,"briefTitle":1078,"status":216,"phases":1301,"primaryCompletion":1080,"completion":1081,"start":1082,"enrollment":1083,"conditions":1302,"interventions":1303},[79],[1085,16],[1085,28,31,1051,28,31],{"intervention":1305,"totalTrials":82,"cells":1306},"EMLA",{"EARLY_PHASE1":1307,"PHASE1":1309,"PHASE2":1311,"PHASE3":1313,"PHASE4":1315,"NA":1317},{"trials":1308,"activeCount":86},[],{"trials":1310,"activeCount":86},[],{"trials":1312,"activeCount":86},[],{"trials":1314,"activeCount":86},[],{"trials":1316,"activeCount":86},[],{"trials":1318,"activeCount":86},[1319],{"nctId":1320,"briefTitle":1321,"status":216,"phases":1322,"primaryCompletion":1106,"completion":1323,"start":1324,"enrollment":1070,"conditions":1325,"interventions":1326},"NCT04076865","Evaluation of the Effect Induced by Repeated Administration of Topical Local Anaesthetic (EMLA) on Itch",[79],"2021-01-01","2019-10-15",[1131,16],[1305],{"intervention":1328,"totalTrials":82,"cells":1329},"Zyclara 3.75 % Topical Cream",{"EARLY_PHASE1":1330,"PHASE1":1332,"PHASE2":1334,"PHASE3":1336,"PHASE4":1338,"NA":1340},{"trials":1331,"activeCount":86},[],{"trials":1333,"activeCount":86},[],{"trials":1335,"activeCount":86},[],{"trials":1337,"activeCount":86},[],{"trials":1339,"activeCount":86},[],{"trials":1341,"activeCount":86},[1342],{"nctId":1343,"briefTitle":1344,"status":1345,"phases":1346,"primaryCompletion":1347,"completion":1348,"start":1349,"enrollment":86,"conditions":1350,"interventions":1351},"NCT03943407","Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch","WITHDRAWN",[79],"2021-06","2022-06","2019-11-01",[16],[1328,1352],"Prudoxin",{"intervention":1352,"totalTrials":82,"cells":1354},{"EARLY_PHASE1":1355,"PHASE1":1357,"PHASE2":1359,"PHASE3":1361,"PHASE4":1363,"NA":1365},{"trials":1356,"activeCount":86},[],{"trials":1358,"activeCount":86},[],{"trials":1360,"activeCount":86},[],{"trials":1362,"activeCount":86},[],{"trials":1364,"activeCount":86},[],{"trials":1366,"activeCount":86},[1367],{"nctId":1343,"briefTitle":1344,"status":1345,"phases":1368,"primaryCompletion":1347,"completion":1348,"start":1349,"enrollment":86,"conditions":1369,"interventions":1370},[79],[16],[1328,1352],{"intervention":1372,"totalTrials":82,"cells":1373},"BAM8-22 2mg\u002Fml",{"EARLY_PHASE1":1374,"PHASE1":1376,"PHASE2":1378,"PHASE3":1380,"PHASE4":1382,"NA":1384},{"trials":1375,"activeCount":86},[],{"trials":1377,"activeCount":86},[],{"trials":1379,"activeCount":86},[],{"trials":1381,"activeCount":86},[],{"trials":1383,"activeCount":86},[],{"trials":1385,"activeCount":86},[1386],{"nctId":1387,"briefTitle":1388,"status":412,"phases":1389,"primaryCompletion":1390,"completion":1391,"start":1082,"enrollment":243,"conditions":1392,"interventions":1393},"NCT04197440","Characterization of Bovine Adrenal Medulla (BAM8-22) as a New Surrogate Model of Non-histaminergic Itch",[79],"2020-05-15","2020-12-15",[16],[1372,1394,1395,1396,1397,1398,1399],"BAM8-22 1mg\u002Fml","BAM8-22 0.5 mg\u002Fml","BAM8-22 with 1 SPT","BAM8-22 with 5 SPT","BAM8-22 with 25 SPT","BAM8-22 with inactivate cowhage spicules",{"intervention":1394,"totalTrials":82,"cells":1401},{"EARLY_PHASE1":1402,"PHASE1":1404,"PHASE2":1406,"PHASE3":1408,"PHASE4":1410,"NA":1412},{"trials":1403,"activeCount":86},[],{"trials":1405,"activeCount":86},[],{"trials":1407,"activeCount":86},[],{"trials":1409,"activeCount":86},[],{"trials":1411,"activeCount":86},[],{"trials":1413,"activeCount":86},[1414],{"nctId":1387,"briefTitle":1388,"status":412,"phases":1415,"primaryCompletion":1390,"completion":1391,"start":1082,"enrollment":243,"conditions":1416,"interventions":1417},[79],[16],[1372,1394,1395,1396,1397,1398,1399],{"intervention":1395,"totalTrials":82,"cells":1419},{"EARLY_PHASE1":1420,"PHASE1":1422,"PHASE2":1424,"PHASE3":1426,"PHASE4":1428,"NA":1430},{"trials":1421,"activeCount":86},[],{"trials":1423,"activeCount":86},[],{"trials":1425,"activeCount":86},[],{"trials":1427,"activeCount":86},[],{"trials":1429,"activeCount":86},[],{"trials":1431,"activeCount":86},[1432],{"nctId":1387,"briefTitle":1388,"status":412,"phases":1433,"primaryCompletion":1390,"completion":1391,"start":1082,"enrollment":243,"conditions":1434,"interventions":1435},[79],[16],[1372,1394,1395,1396,1397,1398,1399],{"intervention":1396,"totalTrials":82,"cells":1437},{"EARLY_PHASE1":1438,"PHASE1":1440,"PHASE2":1442,"PHASE3":1444,"PHASE4":1446,"NA":1448},{"trials":1439,"activeCount":86},[],{"trials":1441,"activeCount":86},[],{"trials":1443,"activeCount":86},[],{"trials":1445,"activeCount":86},[],{"trials":1447,"activeCount":86},[],{"trials":1449,"activeCount":86},[1450],{"nctId":1387,"briefTitle":1388,"status":412,"phases":1451,"primaryCompletion":1390,"completion":1391,"start":1082,"enrollment":243,"conditions":1452,"interventions":1453},[79],[16],[1372,1394,1395,1396,1397,1398,1399],{"intervention":1397,"totalTrials":82,"cells":1455},{"EARLY_PHASE1":1456,"PHASE1":1458,"PHASE2":1460,"PHASE3":1462,"PHASE4":1464,"NA":1466},{"trials":1457,"activeCount":86},[],{"trials":1459,"activeCount":86},[],{"trials":1461,"activeCount":86},[],{"trials":1463,"activeCount":86},[],{"trials":1465,"activeCount":86},[],{"trials":1467,"activeCount":86},[1468],{"nctId":1387,"briefTitle":1388,"status":412,"phases":1469,"primaryCompletion":1390,"completion":1391,"start":1082,"enrollment":243,"conditions":1470,"interventions":1471},[79],[16],[1372,1394,1395,1396,1397,1398,1399],{"intervention":1398,"totalTrials":82,"cells":1473},{"EARLY_PHASE1":1474,"PHASE1":1476,"PHASE2":1478,"PHASE3":1480,"PHASE4":1482,"NA":1484},{"trials":1475,"activeCount":86},[],{"trials":1477,"activeCount":86},[],{"trials":1479,"activeCount":86},[],{"trials":1481,"activeCount":86},[],{"trials":1483,"activeCount":86},[],{"trials":1485,"activeCount":86},[1486],{"nctId":1387,"briefTitle":1388,"status":412,"phases":1487,"primaryCompletion":1390,"completion":1391,"start":1082,"enrollment":243,"conditions":1488,"interventions":1489},[79],[16],[1372,1394,1395,1396,1397,1398,1399],{"intervention":1399,"totalTrials":82,"cells":1491},{"EARLY_PHASE1":1492,"PHASE1":1494,"PHASE2":1496,"PHASE3":1498,"PHASE4":1500,"NA":1502},{"trials":1493,"activeCount":86},[],{"trials":1495,"activeCount":86},[],{"trials":1497,"activeCount":86},[],{"trials":1499,"activeCount":86},[],{"trials":1501,"activeCount":86},[],{"trials":1503,"activeCount":86},[1504],{"nctId":1387,"briefTitle":1388,"status":412,"phases":1505,"primaryCompletion":1390,"completion":1391,"start":1082,"enrollment":243,"conditions":1506,"interventions":1507},[79],[16],[1372,1394,1395,1396,1397,1398,1399],{"intervention":1509,"totalTrials":82,"cells":1510},"Whole genome amplification",{"EARLY_PHASE1":1511,"PHASE1":1513,"PHASE2":1515,"PHASE3":1517,"PHASE4":1519,"NA":1521},{"trials":1512,"activeCount":86},[],{"trials":1514,"activeCount":86},[],{"trials":1516,"activeCount":86},[],{"trials":1518,"activeCount":86},[],{"trials":1520,"activeCount":86},[],{"trials":1522,"activeCount":86},[1523],{"nctId":1524,"briefTitle":1525,"status":216,"phases":1526,"primaryCompletion":1527,"completion":1527,"start":1528,"enrollment":697,"conditions":1529,"interventions":1531},"NCT05453474","Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling",[79],"2023-06-27","2021-08-08",[1530],"Hereditary Diseases",[1509],{"intervention":1533,"totalTrials":82,"cells":1534},"Injection of hypertonic saline",{"EARLY_PHASE1":1535,"PHASE1":1537,"PHASE2":1539,"PHASE3":1541,"PHASE4":1543,"NA":1545},{"trials":1536,"activeCount":86},[],{"trials":1538,"activeCount":86},[],{"trials":1540,"activeCount":86},[],{"trials":1542,"activeCount":86},[],{"trials":1544,"activeCount":86},[],{"trials":1546,"activeCount":86},[1547],{"nctId":1548,"briefTitle":1549,"status":216,"phases":1550,"primaryCompletion":1551,"completion":1551,"start":1552,"enrollment":1553,"conditions":1554,"interventions":1556},"NCT04001218","Head Repositioning Accuracy During Experimental Neck Pain",[79],"2015-09-22","2015-04-09",28,[19,1555],"Neck Pain",[1533,1557],"Injection of Isotonic saline",{"intervention":1557,"totalTrials":82,"cells":1559},{"EARLY_PHASE1":1560,"PHASE1":1562,"PHASE2":1564,"PHASE3":1566,"PHASE4":1568,"NA":1570},{"trials":1561,"activeCount":86},[],{"trials":1563,"activeCount":86},[],{"trials":1565,"activeCount":86},[],{"trials":1567,"activeCount":86},[],{"trials":1569,"activeCount":86},[],{"trials":1571,"activeCount":86},[1572],{"nctId":1548,"briefTitle":1549,"status":216,"phases":1573,"primaryCompletion":1551,"completion":1551,"start":1552,"enrollment":1553,"conditions":1574,"interventions":1575},[79],[19,1555],[1533,1557],{"intervention":1577,"totalTrials":82,"cells":1578},"Nerve Growth Factor",{"EARLY_PHASE1":1579,"PHASE1":1581,"PHASE2":1583,"PHASE3":1585,"PHASE4":1587,"NA":1589},{"trials":1580,"activeCount":86},[],{"trials":1582,"activeCount":86},[],{"trials":1584,"activeCount":86},[],{"trials":1586,"activeCount":86},[],{"trials":1588,"activeCount":86},[],{"trials":1590,"activeCount":86},[1591],{"nctId":1592,"briefTitle":1593,"status":727,"phases":1594,"primaryCompletion":416,"completion":1595,"start":949,"enrollment":1596,"conditions":1597,"interventions":1599},"NCT04457466","Assessment of the Effects of Extensive Somatosensory Training on Pain Processing",[],"2020-07-01",100,[1598],"Musculoskeletal Pain",[1577],{"intervention":1601,"totalTrials":82,"cells":1602},"Topical lidocaine 5%",{"EARLY_PHASE1":1603,"PHASE1":1605,"PHASE2":1607,"PHASE3":1609,"PHASE4":1611,"NA":1613},{"trials":1604,"activeCount":86},[],{"trials":1606,"activeCount":86},[],{"trials":1608,"activeCount":86},[],{"trials":1610,"activeCount":86},[],{"trials":1612,"activeCount":86},[],{"trials":1614,"activeCount":86},[1615],{"nctId":1616,"briefTitle":1617,"status":216,"phases":1618,"primaryCompletion":1619,"completion":1620,"start":1621,"enrollment":209,"conditions":1622,"interventions":1624},"NCT06312254","Pharmacological Modulation of Peripheral Nerve Excitability",[79],"2024-12-02","2024-12-11","2024-04-09",[1623],"Peripheral Neuropathy",[1601,1625,1626],"Topical Phenytoin 10%","Topical Mepyramine 2%",{"intervention":1625,"totalTrials":82,"cells":1628},{"EARLY_PHASE1":1629,"PHASE1":1631,"PHASE2":1633,"PHASE3":1635,"PHASE4":1637,"NA":1639},{"trials":1630,"activeCount":86},[],{"trials":1632,"activeCount":86},[],{"trials":1634,"activeCount":86},[],{"trials":1636,"activeCount":86},[],{"trials":1638,"activeCount":86},[],{"trials":1640,"activeCount":86},[1641],{"nctId":1616,"briefTitle":1617,"status":216,"phases":1642,"primaryCompletion":1619,"completion":1620,"start":1621,"enrollment":209,"conditions":1643,"interventions":1644},[79],[1623],[1601,1625,1626],{"intervention":1626,"totalTrials":82,"cells":1646},{"EARLY_PHASE1":1647,"PHASE1":1649,"PHASE2":1651,"PHASE3":1653,"PHASE4":1655,"NA":1657},{"trials":1648,"activeCount":86},[],{"trials":1650,"activeCount":86},[],{"trials":1652,"activeCount":86},[],{"trials":1654,"activeCount":86},[],{"trials":1656,"activeCount":86},[],{"trials":1658,"activeCount":86},[1659],{"nctId":1616,"briefTitle":1617,"status":216,"phases":1660,"primaryCompletion":1619,"completion":1620,"start":1621,"enrollment":209,"conditions":1661,"interventions":1662},[79],[1623],[1601,1625,1626],{"intervention":1216,"totalTrials":82,"cells":1664},{"EARLY_PHASE1":1665,"PHASE1":1667,"PHASE2":1669,"PHASE3":1671,"PHASE4":1673,"NA":1675},{"trials":1666,"activeCount":86},[],{"trials":1668,"activeCount":86},[],{"trials":1670,"activeCount":86},[],{"trials":1672,"activeCount":86},[],{"trials":1674,"activeCount":86},[],{"trials":1676,"activeCount":86},[1677],{"nctId":1206,"briefTitle":1207,"status":412,"phases":1678,"primaryCompletion":1209,"completion":1209,"start":1210,"enrollment":1211,"conditions":1679,"interventions":1680},[79],[22,1213,1166,1214],[1073,1216,1217,1218],{"intervention":1217,"totalTrials":82,"cells":1682},{"EARLY_PHASE1":1683,"PHASE1":1685,"PHASE2":1687,"PHASE3":1689,"PHASE4":1691,"NA":1693},{"trials":1684,"activeCount":86},[],{"trials":1686,"activeCount":86},[],{"trials":1688,"activeCount":86},[],{"trials":1690,"activeCount":86},[],{"trials":1692,"activeCount":86},[],{"trials":1694,"activeCount":86},[1695],{"nctId":1206,"briefTitle":1207,"status":412,"phases":1696,"primaryCompletion":1209,"completion":1209,"start":1210,"enrollment":1211,"conditions":1697,"interventions":1698},[79],[22,1213,1166,1214],[1073,1216,1217,1218],{"intervention":1218,"totalTrials":82,"cells":1700},{"EARLY_PHASE1":1701,"PHASE1":1703,"PHASE2":1705,"PHASE3":1707,"PHASE4":1709,"NA":1711},{"trials":1702,"activeCount":86},[],{"trials":1704,"activeCount":86},[],{"trials":1706,"activeCount":86},[],{"trials":1708,"activeCount":86},[],{"trials":1710,"activeCount":86},[],{"trials":1712,"activeCount":86},[1713],{"nctId":1206,"briefTitle":1207,"status":412,"phases":1714,"primaryCompletion":1209,"completion":1209,"start":1210,"enrollment":1211,"conditions":1715,"interventions":1716},[79],[22,1213,1166,1214],[1073,1216,1217,1218],{"intervention":1718,"totalTrials":82,"cells":1719},"Ropivacaine",{"EARLY_PHASE1":1720,"PHASE1":1722,"PHASE2":1724,"PHASE3":1726,"PHASE4":1728,"NA":1730},{"trials":1721,"activeCount":86},[],{"trials":1723,"activeCount":86},[],{"trials":1725,"activeCount":86},[],{"trials":1727,"activeCount":86},[],{"trials":1729,"activeCount":86},[],{"trials":1731,"activeCount":86},[1732],{"nctId":1733,"briefTitle":1734,"status":727,"phases":1735,"primaryCompletion":695,"completion":1736,"start":1737,"enrollment":280,"conditions":1738,"interventions":1742},"NCT01760161","Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery",[79],"2016-02","2014-04",[1739,1740,1741],"Pain Treatment","Robotic Assisted Laparoscopic Surgery","Bilateral Dual Transversus Abdominis Plane Block",[1718,1743],"Isotonic potassium chloride",{"intervention":1743,"totalTrials":82,"cells":1745},{"EARLY_PHASE1":1746,"PHASE1":1748,"PHASE2":1750,"PHASE3":1752,"PHASE4":1754,"NA":1756},{"trials":1747,"activeCount":86},[],{"trials":1749,"activeCount":86},[],{"trials":1751,"activeCount":86},[],{"trials":1753,"activeCount":86},[],{"trials":1755,"activeCount":86},[],{"trials":1757,"activeCount":86},[1758],{"nctId":1733,"briefTitle":1734,"status":727,"phases":1759,"primaryCompletion":695,"completion":1736,"start":1737,"enrollment":280,"conditions":1760,"interventions":1761},[79],[1739,1740,1741],[1718,1743],{"intervention":1763,"totalTrials":82,"cells":1764},"GABA oral solution",{"EARLY_PHASE1":1765,"PHASE1":1767,"PHASE2":1769,"PHASE3":1771,"PHASE4":1773,"NA":1775},{"trials":1766,"activeCount":86},[],{"trials":1768,"activeCount":86},[],{"trials":1770,"activeCount":86},[],{"trials":1772,"activeCount":86},[],{"trials":1774,"activeCount":86},[],{"trials":1776,"activeCount":86},[1777],{"nctId":1778,"briefTitle":1779,"status":412,"phases":1780,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1785,"interventions":1786},"NCT02928328","Assessment of Peripheral GABA Receptors for Local Pain Relief",[79],"2018-12","2019-12","2016-10",90,[22],[1763,1787,1788],"Intramuscular GABA","Pain modulation",{"intervention":1787,"totalTrials":82,"cells":1790},{"EARLY_PHASE1":1791,"PHASE1":1793,"PHASE2":1795,"PHASE3":1797,"PHASE4":1799,"NA":1801},{"trials":1792,"activeCount":86},[],{"trials":1794,"activeCount":86},[],{"trials":1796,"activeCount":86},[],{"trials":1798,"activeCount":86},[],{"trials":1800,"activeCount":86},[],{"trials":1802,"activeCount":86},[1803],{"nctId":1778,"briefTitle":1779,"status":412,"phases":1804,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1805,"interventions":1806},[79],[22],[1763,1787,1788],{"intervention":1788,"totalTrials":82,"cells":1808},{"EARLY_PHASE1":1809,"PHASE1":1811,"PHASE2":1813,"PHASE3":1815,"PHASE4":1817,"NA":1819},{"trials":1810,"activeCount":86},[],{"trials":1812,"activeCount":86},[],{"trials":1814,"activeCount":86},[],{"trials":1816,"activeCount":86},[],{"trials":1818,"activeCount":86},[],{"trials":1820,"activeCount":86},[1821],{"nctId":1778,"briefTitle":1779,"status":412,"phases":1822,"primaryCompletion":1781,"completion":1782,"start":1783,"enrollment":1784,"conditions":1823,"interventions":1824},[79],[22],[1763,1787,1788],{"intervention":1826,"totalTrials":82,"cells":1827},"Emla 1 hour",{"EARLY_PHASE1":1828,"PHASE1":1830,"PHASE2":1832,"PHASE3":1834,"PHASE4":1836,"NA":1838},{"trials":1829,"activeCount":86},[],{"trials":1831,"activeCount":86},[],{"trials":1833,"activeCount":86},[],{"trials":1835,"activeCount":86},[],{"trials":1837,"activeCount":86},[],{"trials":1839,"activeCount":86},[1840],{"nctId":1841,"briefTitle":1842,"status":216,"phases":1843,"primaryCompletion":1844,"completion":98,"start":1845,"enrollment":1211,"conditions":1846,"interventions":1847},"NCT04858360","Inhibition of Non-histaminergic Pruritus Applied Using 3 Different Pruritogens",[79],"2022-08-01","2021-11-15",[16],[1826,1848],"EMLA 3 hours",{"intervention":1848,"totalTrials":82,"cells":1850},{"EARLY_PHASE1":1851,"PHASE1":1853,"PHASE2":1855,"PHASE3":1857,"PHASE4":1859,"NA":1861},{"trials":1852,"activeCount":86},[],{"trials":1854,"activeCount":86},[],{"trials":1856,"activeCount":86},[],{"trials":1858,"activeCount":86},[],{"trials":1860,"activeCount":86},[],{"trials":1862,"activeCount":86},[1863],{"nctId":1841,"briefTitle":1842,"status":216,"phases":1864,"primaryCompletion":1844,"completion":98,"start":1845,"enrollment":1211,"conditions":1865,"interventions":1866},[79],[16],[1826,1848],{"intervention":1868,"totalTrials":82,"cells":1869},"A-967079 and BAM8-22 application",{"EARLY_PHASE1":1870,"PHASE1":1872,"PHASE2":1874,"PHASE3":1876,"PHASE4":1878,"NA":1880},{"trials":1871,"activeCount":86},[],{"trials":1873,"activeCount":86},[],{"trials":1875,"activeCount":86},[],{"trials":1877,"activeCount":86},[],{"trials":1879,"activeCount":86},[],{"trials":1881,"activeCount":86},[1882],{"nctId":1883,"briefTitle":1884,"status":216,"phases":1885,"primaryCompletion":253,"completion":254,"start":1886,"enrollment":1211,"conditions":1887,"interventions":1888},"NCT05249387","Characterization of Bovine Adrenal Medulla as a New Surrogate Model of Non-histaminergic Itch",[79],"2022-02-11",[16],[1868,1889,1890,1891],"A-967079 and BAM8-22 application after 5 minutes.","A-967079 application.","Vehicle and BAM8-22 application.",{"intervention":1889,"totalTrials":82,"cells":1893},{"EARLY_PHASE1":1894,"PHASE1":1896,"PHASE2":1898,"PHASE3":1900,"PHASE4":1902,"NA":1904},{"trials":1895,"activeCount":86},[],{"trials":1897,"activeCount":86},[],{"trials":1899,"activeCount":86},[],{"trials":1901,"activeCount":86},[],{"trials":1903,"activeCount":86},[],{"trials":1905,"activeCount":86},[1906],{"nctId":1883,"briefTitle":1884,"status":216,"phases":1907,"primaryCompletion":253,"completion":254,"start":1886,"enrollment":1211,"conditions":1908,"interventions":1909},[79],[16],[1868,1889,1890,1891],{"intervention":1890,"totalTrials":82,"cells":1911},{"EARLY_PHASE1":1912,"PHASE1":1914,"PHASE2":1916,"PHASE3":1918,"PHASE4":1920,"NA":1922},{"trials":1913,"activeCount":86},[],{"trials":1915,"activeCount":86},[],{"trials":1917,"activeCount":86},[],{"trials":1919,"activeCount":86},[],{"trials":1921,"activeCount":86},[],{"trials":1923,"activeCount":86},[1924],{"nctId":1883,"briefTitle":1884,"status":216,"phases":1925,"primaryCompletion":253,"completion":254,"start":1886,"enrollment":1211,"conditions":1926,"interventions":1927},[79],[16],[1868,1889,1890,1891],{"intervention":1891,"totalTrials":82,"cells":1929},{"EARLY_PHASE1":1930,"PHASE1":1932,"PHASE2":1934,"PHASE3":1936,"PHASE4":1938,"NA":1940},{"trials":1931,"activeCount":86},[],{"trials":1933,"activeCount":86},[],{"trials":1935,"activeCount":86},[],{"trials":1937,"activeCount":86},[],{"trials":1939,"activeCount":86},[],{"trials":1941,"activeCount":86},[1942],{"nctId":1883,"briefTitle":1884,"status":216,"phases":1943,"primaryCompletion":253,"completion":254,"start":1886,"enrollment":1211,"conditions":1944,"interventions":1945},[79],[16],[1868,1889,1890,1891],{"intervention":1947,"totalTrials":82,"cells":1948},"NSAID",{"EARLY_PHASE1":1949,"PHASE1":1951,"PHASE2":1953,"PHASE3":1955,"PHASE4":1957,"NA":1959},{"trials":1950,"activeCount":86},[],{"trials":1952,"activeCount":86},[],{"trials":1954,"activeCount":86},[],{"trials":1956,"activeCount":86},[],{"trials":1958,"activeCount":86},[],{"trials":1960,"activeCount":86},[1961],{"nctId":1962,"briefTitle":1963,"status":216,"phases":1964,"primaryCompletion":1965,"completion":1966,"start":1967,"enrollment":1968,"conditions":1969,"interventions":1971},"NCT02967744","NSAID Treatment of Patients With Osteoarthritis",[79],"2018-01","2018-02-01","2016-01",162,[1970],"Osteoarthritis,Knee",[1947],{"intervention":1973,"totalTrials":82,"cells":1974},"Papain 10 µg",{"EARLY_PHASE1":1975,"PHASE1":1977,"PHASE2":1979,"PHASE3":1981,"PHASE4":1983,"NA":1985},{"trials":1976,"activeCount":86},[],{"trials":1978,"activeCount":86},[],{"trials":1980,"activeCount":86},[],{"trials":1982,"activeCount":86},[],{"trials":1984,"activeCount":86},[],{"trials":1986,"activeCount":86},[1987],{"nctId":1988,"briefTitle":1989,"status":216,"phases":1990,"primaryCompletion":798,"completion":798,"start":1991,"enrollment":209,"conditions":1992,"interventions":1994},"NCT04515056","Characterization of New Human Models of Non-histaminergic Itch",[79],"2020-09-01",[1129,16,1993],"Skin Prick Test (SPT)",[1973,1995,1996,1997,1998,1999],"Papain 50 µg","Papain 100 µg","Papain 1 SPT","Papain 5 SPT","Papain 25 SPT",{"intervention":1995,"totalTrials":82,"cells":2001},{"EARLY_PHASE1":2002,"PHASE1":2004,"PHASE2":2006,"PHASE3":2008,"PHASE4":2010,"NA":2012},{"trials":2003,"activeCount":86},[],{"trials":2005,"activeCount":86},[],{"trials":2007,"activeCount":86},[],{"trials":2009,"activeCount":86},[],{"trials":2011,"activeCount":86},[],{"trials":2013,"activeCount":86},[2014],{"nctId":1988,"briefTitle":1989,"status":216,"phases":2015,"primaryCompletion":798,"completion":798,"start":1991,"enrollment":209,"conditions":2016,"interventions":2017},[79],[1129,16,1993],[1973,1995,1996,1997,1998,1999],{"intervention":1996,"totalTrials":82,"cells":2019},{"EARLY_PHASE1":2020,"PHASE1":2022,"PHASE2":2024,"PHASE3":2026,"PHASE4":2028,"NA":2030},{"trials":2021,"activeCount":86},[],{"trials":2023,"activeCount":86},[],{"trials":2025,"activeCount":86},[],{"trials":2027,"activeCount":86},[],{"trials":2029,"activeCount":86},[],{"trials":2031,"activeCount":86},[2032],{"nctId":1988,"briefTitle":1989,"status":216,"phases":2033,"primaryCompletion":798,"completion":798,"start":1991,"enrollment":209,"conditions":2034,"interventions":2035},[79],[1129,16,1993],[1973,1995,1996,1997,1998,1999],{"intervention":1997,"totalTrials":82,"cells":2037},{"EARLY_PHASE1":2038,"PHASE1":2040,"PHASE2":2042,"PHASE3":2044,"PHASE4":2046,"NA":2048},{"trials":2039,"activeCount":86},[],{"trials":2041,"activeCount":86},[],{"trials":2043,"activeCount":86},[],{"trials":2045,"activeCount":86},[],{"trials":2047,"activeCount":86},[],{"trials":2049,"activeCount":86},[2050],{"nctId":1988,"briefTitle":1989,"status":216,"phases":2051,"primaryCompletion":798,"completion":798,"start":1991,"enrollment":209,"conditions":2052,"interventions":2053},[79],[1129,16,1993],[1973,1995,1996,1997,1998,1999],{"intervention":1998,"totalTrials":82,"cells":2055},{"EARLY_PHASE1":2056,"PHASE1":2058,"PHASE2":2060,"PHASE3":2062,"PHASE4":2064,"NA":2066},{"trials":2057,"activeCount":86},[],{"trials":2059,"activeCount":86},[],{"trials":2061,"activeCount":86},[],{"trials":2063,"activeCount":86},[],{"trials":2065,"activeCount":86},[],{"trials":2067,"activeCount":86},[2068],{"nctId":1988,"briefTitle":1989,"status":216,"phases":2069,"primaryCompletion":798,"completion":798,"start":1991,"enrollment":209,"conditions":2070,"interventions":2071},[79],[1129,16,1993],[1973,1995,1996,1997,1998,1999],{"intervention":1999,"totalTrials":82,"cells":2073},{"EARLY_PHASE1":2074,"PHASE1":2076,"PHASE2":2078,"PHASE3":2080,"PHASE4":2082,"NA":2084},{"trials":2075,"activeCount":86},[],{"trials":2077,"activeCount":86},[],{"trials":2079,"activeCount":86},[],{"trials":2081,"activeCount":86},[],{"trials":2083,"activeCount":86},[],{"trials":2085,"activeCount":86},[2086],{"nctId":1988,"briefTitle":1989,"status":216,"phases":2087,"primaryCompletion":798,"completion":798,"start":1991,"enrollment":209,"conditions":2088,"interventions":2089},[79],[1129,16,1993],[1973,1995,1996,1997,1998,1999],{"intervention":2091,"totalTrials":82,"cells":2092},"Propofol",{"EARLY_PHASE1":2093,"PHASE1":2095,"PHASE2":2097,"PHASE3":2099,"PHASE4":2101,"NA":2103},{"trials":2094,"activeCount":86},[],{"trials":2096,"activeCount":86},[],{"trials":2098,"activeCount":86},[],{"trials":2100,"activeCount":86},[],{"trials":2102,"activeCount":86},[],{"trials":2104,"activeCount":86},[2105],{"nctId":2106,"briefTitle":2107,"status":727,"phases":2108,"primaryCompletion":2109,"completion":2109,"start":2110,"enrollment":2111,"conditions":2112,"interventions":2114},"NCT01043952","Use of Bispectral Index (BIS) for Monitoring of Total Intravenous Anaesthesia in Pediatric Patients",[79],"2012-03","2010-01",157,[2113],"Anesthesia, General",[2091,2115],"Remifentanil",{"intervention":2115,"totalTrials":82,"cells":2117},{"EARLY_PHASE1":2118,"PHASE1":2120,"PHASE2":2122,"PHASE3":2124,"PHASE4":2126,"NA":2128},{"trials":2119,"activeCount":86},[],{"trials":2121,"activeCount":86},[],{"trials":2123,"activeCount":86},[],{"trials":2125,"activeCount":86},[],{"trials":2127,"activeCount":86},[],{"trials":2129,"activeCount":86},[2130],{"nctId":2106,"briefTitle":2107,"status":727,"phases":2131,"primaryCompletion":2109,"completion":2109,"start":2110,"enrollment":2111,"conditions":2132,"interventions":2133},[79],[2113],[2091,2115],{"intervention":2135,"totalTrials":82,"cells":2136},"Exercises and CSI",{"EARLY_PHASE1":2137,"PHASE1":2139,"PHASE2":2141,"PHASE3":2143,"PHASE4":2145,"NA":2147},{"trials":2138,"activeCount":86},[],{"trials":2140,"activeCount":86},[],{"trials":2142,"activeCount":86},[],{"trials":2144,"activeCount":86},[],{"trials":2146,"activeCount":86},[],{"trials":2148,"activeCount":86},[2149],{"nctId":2150,"briefTitle":2151,"status":412,"phases":2152,"primaryCompletion":2153,"completion":2154,"start":2155,"enrollment":209,"conditions":2156,"interventions":2159},"NCT05086926","Feasibility of Home Exercises With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain in General Practice",[79],"2021-12","2022-02","2021-10",[2157,2158,211],"Lateral Hip Pain","Gluteal Tendinopathy",[2135],{"intervention":2161,"totalTrials":82,"cells":2162},"Capsaicin Topical - alone",{"EARLY_PHASE1":2163,"PHASE1":2165,"PHASE2":2167,"PHASE3":2169,"PHASE4":2171,"NA":2173},{"trials":2164,"activeCount":86},[],{"trials":2166,"activeCount":86},[],{"trials":2168,"activeCount":86},[],{"trials":2170,"activeCount":86},[],{"trials":2172,"activeCount":86},[],{"trials":2174,"activeCount":86},[2175],{"nctId":2176,"briefTitle":2177,"status":412,"phases":2178,"primaryCompletion":2179,"completion":2179,"start":1595,"enrollment":1083,"conditions":2180,"interventions":2181},"NCT04485689","The Effect of Capsaicin-induced Pain on Homeostatic Plasticity in Healthy Human Participants",[79],"2020-12",[19],[2161,2182],"Capsaicin Topical - ice",{"intervention":2182,"totalTrials":82,"cells":2184},{"EARLY_PHASE1":2185,"PHASE1":2187,"PHASE2":2189,"PHASE3":2191,"PHASE4":2193,"NA":2195},{"trials":2186,"activeCount":86},[],{"trials":2188,"activeCount":86},[],{"trials":2190,"activeCount":86},[],{"trials":2192,"activeCount":86},[],{"trials":2194,"activeCount":86},[],{"trials":2196,"activeCount":86},[2197],{"nctId":2176,"briefTitle":2177,"status":412,"phases":2198,"primaryCompletion":2179,"completion":2179,"start":1595,"enrollment":1083,"conditions":2199,"interventions":2200},[79],[19],[2161,2182],{"intervention":2202,"totalTrials":82,"cells":2203},"Anti-histamine cream 1 hour",{"EARLY_PHASE1":2204,"PHASE1":2206,"PHASE2":2208,"PHASE3":2210,"PHASE4":2212,"NA":2214},{"trials":2205,"activeCount":86},[],{"trials":2207,"activeCount":86},[],{"trials":2209,"activeCount":86},[],{"trials":2211,"activeCount":86},[],{"trials":2213,"activeCount":86},[],{"trials":2215,"activeCount":86},[2216],{"nctId":2217,"briefTitle":2218,"status":412,"phases":2219,"primaryCompletion":2220,"completion":2220,"start":2221,"enrollment":209,"conditions":2222,"interventions":2223},"NCT05195177","Testing Protocol to Efficiently Induce Itch",[79],"2023-12-20","2021-11-25",[16],[2202,2224],"Local anesthetic cream 1 hour",{"intervention":2224,"totalTrials":82,"cells":2226},{"EARLY_PHASE1":2227,"PHASE1":2229,"PHASE2":2231,"PHASE3":2233,"PHASE4":2235,"NA":2237},{"trials":2228,"activeCount":86},[],{"trials":2230,"activeCount":86},[],{"trials":2232,"activeCount":86},[],{"trials":2234,"activeCount":86},[],{"trials":2236,"activeCount":86},[],{"trials":2238,"activeCount":86},[2239],{"nctId":2217,"briefTitle":2218,"status":412,"phases":2240,"primaryCompletion":2220,"completion":2220,"start":2221,"enrollment":209,"conditions":2241,"interventions":2242},[79],[16],[2202,2224],{"intervention":1109,"totalTrials":82,"cells":2244},{"EARLY_PHASE1":2245,"PHASE1":2247,"PHASE2":2249,"PHASE3":2251,"PHASE4":2253,"NA":2255},{"trials":2246,"activeCount":86},[],{"trials":2248,"activeCount":86},[],{"trials":2250,"activeCount":86},[],{"trials":2252,"activeCount":86},[],{"trials":2254,"activeCount":86},[],{"trials":2256,"activeCount":86},[2257],{"nctId":1102,"briefTitle":1103,"status":216,"phases":2258,"primaryCompletion":1105,"completion":798,"start":1106,"enrollment":1083,"conditions":2259,"interventions":2260},[79],[16],[1109,28,31,1110],{"intervention":1110,"totalTrials":82,"cells":2262},{"EARLY_PHASE1":2263,"PHASE1":2265,"PHASE2":2267,"PHASE3":2269,"PHASE4":2271,"NA":2273},{"trials":2264,"activeCount":86},[],{"trials":2266,"activeCount":86},[],{"trials":2268,"activeCount":86},[],{"trials":2270,"activeCount":86},[],{"trials":2272,"activeCount":86},[],{"trials":2274,"activeCount":86},[2275],{"nctId":1102,"briefTitle":1103,"status":216,"phases":2276,"primaryCompletion":1105,"completion":798,"start":1106,"enrollment":1083,"conditions":2277,"interventions":2278},[79],[16],[1109,28,31,1110],{"intervention":1168,"totalTrials":82,"cells":2280},{"EARLY_PHASE1":2281,"PHASE1":2283,"PHASE2":2285,"PHASE3":2287,"PHASE4":2289,"NA":2291},{"trials":2282,"activeCount":86},[],{"trials":2284,"activeCount":86},[],{"trials":2286,"activeCount":86},[],{"trials":2288,"activeCount":86},[],{"trials":2290,"activeCount":86},[],{"trials":2292,"activeCount":86},[2293],{"nctId":1158,"briefTitle":1159,"status":216,"phases":2294,"primaryCompletion":1161,"completion":1162,"start":1163,"enrollment":1059,"conditions":2295,"interventions":2296},[79],[1073,1165,1166,1131],[1168,1131],{"intervention":2298,"totalTrials":82,"cells":2299},"Botox",{"EARLY_PHASE1":2300,"PHASE1":2302,"PHASE2":2304,"PHASE3":2306,"PHASE4":2308,"NA":2310},{"trials":2301,"activeCount":86},[],{"trials":2303,"activeCount":86},[],{"trials":2305,"activeCount":86},[],{"trials":2307,"activeCount":86},[],{"trials":2309,"activeCount":86},[],{"trials":2311,"activeCount":86},[2312],{"nctId":2313,"briefTitle":2314,"status":216,"phases":2315,"primaryCompletion":487,"completion":487,"start":651,"conditions":2316,"interventions":2317},"NCT00435682","To Study the Peripheral Effect of Botulinum Toxin-A (Botox-A) on Experimentally Induced Cutaneous Pain in Healthy Subjects",[79],[19],[2298],{"intervention":2319,"totalTrials":82,"cells":2320},"Topical alone",{"EARLY_PHASE1":2321,"PHASE1":2323,"PHASE2":2325,"PHASE3":2327,"PHASE4":2329,"NA":2331},{"trials":2322,"activeCount":86},[],{"trials":2324,"activeCount":86},[],{"trials":2326,"activeCount":86},[],{"trials":2328,"activeCount":86},[],{"trials":2330,"activeCount":86},[],{"trials":2332,"activeCount":86},[2333],{"nctId":2334,"briefTitle":2335,"status":216,"phases":2336,"primaryCompletion":2337,"completion":2337,"start":2338,"enrollment":20,"conditions":2339,"interventions":2340},"NCT06197529","Is Nociceptive Processing Evoked by Heat Homeostatically Regulated: A Contact-heat Evoked Potentials Study",[79],"2024-03-04","2023-11-21",[19],[2319],{"intervention":2342,"totalTrials":82,"cells":2343},"Ropivacaine bolus in transversus abdominis plane catheter",{"EARLY_PHASE1":2344,"PHASE1":2346,"PHASE2":2348,"PHASE3":2350,"PHASE4":2352,"NA":2354},{"trials":2345,"activeCount":86},[],{"trials":2347,"activeCount":86},[],{"trials":2349,"activeCount":86},[],{"trials":2351,"activeCount":86},[],{"trials":2353,"activeCount":86},[],{"trials":2355,"activeCount":86},[2356],{"nctId":2357,"briefTitle":2358,"status":1345,"phases":2359,"primaryCompletion":2360,"completion":2361,"start":1967,"enrollment":86,"conditions":2362,"interventions":2364},"NCT01760174","Comparing the Effect of TAP-catheter and Epidural Catheter on Postoperative Pain After Open Gynecologic Surgery",[79],"2016-12","2017-02",[2363],"Pain, Postoperative",[2342,2365],"Bupivacain-infusion in epidural catheter",{"intervention":2365,"totalTrials":82,"cells":2367},{"EARLY_PHASE1":2368,"PHASE1":2370,"PHASE2":2372,"PHASE3":2374,"PHASE4":2376,"NA":2378},{"trials":2369,"activeCount":86},[],{"trials":2371,"activeCount":86},[],{"trials":2373,"activeCount":86},[],{"trials":2375,"activeCount":86},[],{"trials":2377,"activeCount":86},[],{"trials":2379,"activeCount":86},[2380],{"nctId":2357,"briefTitle":2358,"status":1345,"phases":2381,"primaryCompletion":2360,"completion":2361,"start":1967,"enrollment":86,"conditions":2382,"interventions":2383},[79],[2363],[2342,2365],{"intervention":2385,"totalTrials":82,"cells":2386},"Bupivacain 2.5 mg\u002Fml with epinephrine bolus in TAP-catheters",{"EARLY_PHASE1":2387,"PHASE1":2389,"PHASE2":2391,"PHASE3":2393,"PHASE4":2395,"NA":2397},{"trials":2388,"activeCount":86},[],{"trials":2390,"activeCount":86},[],{"trials":2392,"activeCount":86},[],{"trials":2394,"activeCount":86},[],{"trials":2396,"activeCount":86},[],{"trials":2398,"activeCount":86},[2399],{"nctId":2400,"briefTitle":2401,"status":216,"phases":2402,"primaryCompletion":2403,"completion":2403,"start":537,"enrollment":2404,"conditions":2405,"interventions":2406},"NCT01395043","Transversus Abdominis Plane Catheter: a Study of Method",[79],"2011-06",15,[542],[2385],{"intervention":2408,"totalTrials":82,"cells":2409},"Ketamine 0.5%",{"EARLY_PHASE1":2410,"PHASE1":2412,"PHASE2":2414,"PHASE3":2416,"PHASE4":2418,"NA":2420},{"trials":2411,"activeCount":86},[],{"trials":2413,"activeCount":86},[],{"trials":2415,"activeCount":86},[],{"trials":2417,"activeCount":86},[],{"trials":2419,"activeCount":86},[],{"trials":2421,"activeCount":86},[2422],{"nctId":2423,"briefTitle":2424,"status":216,"phases":2425,"primaryCompletion":1056,"completion":1056,"start":2426,"enrollment":243,"conditions":2427,"interventions":2428},"NCT06245564","Effect of Ketamine, Amitriptyline and Their Combination on Itch",[79],"2024-08-20",[16],[2408,2429,2430],"Amitriptyline","ketamine + amitriptyline",{"intervention":2429,"totalTrials":82,"cells":2432},{"EARLY_PHASE1":2433,"PHASE1":2435,"PHASE2":2437,"PHASE3":2439,"PHASE4":2441,"NA":2443},{"trials":2434,"activeCount":86},[],{"trials":2436,"activeCount":86},[],{"trials":2438,"activeCount":86},[],{"trials":2440,"activeCount":86},[],{"trials":2442,"activeCount":86},[],{"trials":2444,"activeCount":86},[2445],{"nctId":2423,"briefTitle":2424,"status":216,"phases":2446,"primaryCompletion":1056,"completion":1056,"start":2426,"enrollment":243,"conditions":2447,"interventions":2448},[79],[16],[2408,2429,2430],{"intervention":2430,"totalTrials":82,"cells":2450},{"EARLY_PHASE1":2451,"PHASE1":2453,"PHASE2":2455,"PHASE3":2457,"PHASE4":2459,"NA":2461},{"trials":2452,"activeCount":86},[],{"trials":2454,"activeCount":86},[],{"trials":2456,"activeCount":86},[],{"trials":2458,"activeCount":86},[],{"trials":2460,"activeCount":86},[],{"trials":2462,"activeCount":86},[2463],{"nctId":2423,"briefTitle":2424,"status":216,"phases":2464,"primaryCompletion":1056,"completion":1056,"start":2426,"enrollment":243,"conditions":2465,"interventions":2466},[79],[16],[2408,2429,2430],{"intervention":1074,"totalTrials":82,"cells":2468},{"EARLY_PHASE1":2469,"PHASE1":2471,"PHASE2":2473,"PHASE3":2475,"PHASE4":2477,"NA":2479},{"trials":2470,"activeCount":86},[],{"trials":2472,"activeCount":86},[],{"trials":2474,"activeCount":86},[],{"trials":2476,"activeCount":86},[],{"trials":2478,"activeCount":86},[],{"trials":2480,"activeCount":86},[2481],{"nctId":1065,"briefTitle":1066,"status":216,"phases":2482,"primaryCompletion":1068,"completion":1068,"start":1069,"enrollment":1070,"conditions":2483,"interventions":2484},[79],[16],[1073,1074,1075,855,28],{"intervention":1075,"totalTrials":82,"cells":2486},{"EARLY_PHASE1":2487,"PHASE1":2489,"PHASE2":2491,"PHASE3":2493,"PHASE4":2495,"NA":2497},{"trials":2488,"activeCount":86},[],{"trials":2490,"activeCount":86},[],{"trials":2492,"activeCount":86},[],{"trials":2494,"activeCount":86},[],{"trials":2496,"activeCount":86},[],{"trials":2498,"activeCount":86},[2499],{"nctId":1065,"briefTitle":1066,"status":216,"phases":2500,"primaryCompletion":1068,"completion":1068,"start":1069,"enrollment":1070,"conditions":2501,"interventions":2502},[79],[16],[1073,1074,1075,855,28],{"intervention":2504,"totalTrials":82,"cells":2505},"Liraglutide treatment",{"EARLY_PHASE1":2506,"PHASE1":2508,"PHASE2":2510,"PHASE3":2512,"PHASE4":2514,"NA":2516},{"trials":2507,"activeCount":86},[],{"trials":2509,"activeCount":86},[],{"trials":2511,"activeCount":86},[],{"trials":2513,"activeCount":86},[],{"trials":2515,"activeCount":86},[],{"trials":2517,"activeCount":86},[2518],{"nctId":2519,"briefTitle":2520,"status":216,"phases":2521,"primaryCompletion":2361,"completion":2361,"start":2522,"enrollment":2523,"conditions":2524,"interventions":2527},"NCT02138045","Treatment of Diabetic Neuropathy With Liraglutide",[79],"2014-05",39,[2525,2526],"Diabetes Mellitus, Type 1","Type 1 Diabetes Mellitus",[2504],{"intervention":2529,"totalTrials":82,"cells":2530},"Sterile solutions of recombinant human nerve growth factor",{"EARLY_PHASE1":2531,"PHASE1":2533,"PHASE2":2535,"PHASE3":2537,"PHASE4":2539,"NA":2541},{"trials":2532,"activeCount":86},[],{"trials":2534,"activeCount":86},[],{"trials":2536,"activeCount":86},[],{"trials":2538,"activeCount":86},[],{"trials":2540,"activeCount":86},[],{"trials":2542,"activeCount":86},[2543],{"nctId":2544,"briefTitle":2545,"status":216,"phases":2546,"primaryCompletion":2547,"completion":2547,"start":2548,"enrollment":1083,"conditions":2549,"interventions":2553},"NCT03354624","Cortical Neuroplasticity by Muscle Pain of Pain-induced Plasticity",[79],"2018-02-28","2017-11-26",[1577,2550,2551,2552,941],"Exercise","Motor Activity","Abnormality of SSEPs",[2529],{"intervention":2555,"totalTrials":82,"cells":2556},"Focused shockwave therapy",{"EARLY_PHASE1":2557,"PHASE1":2559,"PHASE2":2561,"PHASE3":2563,"PHASE4":2565,"NA":2567},{"trials":2558,"activeCount":86},[],{"trials":2560,"activeCount":86},[],{"trials":2562,"activeCount":86},[],{"trials":2564,"activeCount":86},[],{"trials":2566,"activeCount":86},[],{"trials":2568,"activeCount":86},[2569],{"nctId":2570,"briefTitle":2571,"status":412,"phases":2572,"primaryCompletion":2573,"completion":2574,"start":799,"enrollment":826,"conditions":2575,"interventions":2577},"NCT04058509","Clinical Predictors of Extracorporal Shockwave Therapy Efficacy in Patients Presenting With Lateral Hip Pain",[79],"2019-12-30","2020-07-30",[2576],"Tendinopathy",[2555],{"intervention":259,"totalTrials":82,"cells":2579},{"EARLY_PHASE1":2580,"PHASE1":2582,"PHASE2":2584,"PHASE3":2586,"PHASE4":2588,"NA":2590},{"trials":2581,"activeCount":86},[],{"trials":2583,"activeCount":86},[],{"trials":2585,"activeCount":86},[],{"trials":2587,"activeCount":86},[],{"trials":2589,"activeCount":86},[],{"trials":2591,"activeCount":86},[2592],{"nctId":250,"briefTitle":251,"status":216,"phases":2593,"primaryCompletion":253,"completion":254,"start":255,"enrollment":256,"conditions":2594,"interventions":2595},[79],[16],[259,260,261,262],{"intervention":260,"totalTrials":82,"cells":2597},{"EARLY_PHASE1":2598,"PHASE1":2600,"PHASE2":2602,"PHASE3":2604,"PHASE4":2606,"NA":2608},{"trials":2599,"activeCount":86},[],{"trials":2601,"activeCount":86},[],{"trials":2603,"activeCount":86},[],{"trials":2605,"activeCount":86},[],{"trials":2607,"activeCount":86},[],{"trials":2609,"activeCount":86},[2610],{"nctId":250,"briefTitle":251,"status":216,"phases":2611,"primaryCompletion":253,"completion":254,"start":255,"enrollment":256,"conditions":2612,"interventions":2613},[79],[16],[259,260,261,262],{"intervention":261,"totalTrials":82,"cells":2615},{"EARLY_PHASE1":2616,"PHASE1":2618,"PHASE2":2620,"PHASE3":2622,"PHASE4":2624,"NA":2626},{"trials":2617,"activeCount":86},[],{"trials":2619,"activeCount":86},[],{"trials":2621,"activeCount":86},[],{"trials":2623,"activeCount":86},[],{"trials":2625,"activeCount":86},[],{"trials":2627,"activeCount":86},[2628],{"nctId":250,"briefTitle":251,"status":216,"phases":2629,"primaryCompletion":253,"completion":254,"start":255,"enrollment":256,"conditions":2630,"interventions":2631},[79],[16],[259,260,261,262],{"intervention":1128,"totalTrials":82,"cells":2633},{"EARLY_PHASE1":2634,"PHASE1":2636,"PHASE2":2638,"PHASE3":2640,"PHASE4":2642,"NA":2644},{"trials":2635,"activeCount":86},[],{"trials":2637,"activeCount":86},[],{"trials":2639,"activeCount":86},[],{"trials":2641,"activeCount":86},[],{"trials":2643,"activeCount":86},[],{"trials":2645,"activeCount":86},[2646],{"nctId":1120,"briefTitle":1121,"status":216,"phases":2647,"primaryCompletion":1123,"completion":1124,"start":1125,"enrollment":209,"conditions":2648,"interventions":2649},[79],[16],[1128,1129,28],{"intervention":1129,"totalTrials":82,"cells":2651},{"EARLY_PHASE1":2652,"PHASE1":2654,"PHASE2":2656,"PHASE3":2658,"PHASE4":2660,"NA":2662},{"trials":2653,"activeCount":86},[],{"trials":2655,"activeCount":86},[],{"trials":2657,"activeCount":86},[],{"trials":2659,"activeCount":86},[],{"trials":2661,"activeCount":86},[],{"trials":2663,"activeCount":86},[2664],{"nctId":1120,"briefTitle":1121,"status":216,"phases":2665,"primaryCompletion":1123,"completion":1124,"start":1125,"enrollment":209,"conditions":2666,"interventions":2667},[79],[16],[1128,1129,28]]